Skip to main content

Closed

VRAX: Virax Biolabs Group Limited Financial Statements & Revenue | finqOS

Healthcare · Biotechnology

52W Range

1thpctl

Volume

0.03×avg

Market Cap

488958USD

P/E Ratio

-0.2TTM

Div Yield

-ann

Virax Biolabs Group Limited

VRAXNASDAQ·USD·Closed

Virax Biolabs Group Limited

VRAXNASDAQ·USD·Closed

$2.62

−6.43%

$2.62

−$0.18 (6.43%)

52W Range

1thpctl

Volume

0.03×avg

Mkt Cap

488958USD

P/E

-0.2TTM

Div Yield

–ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings